Selected article for: "drug development and infectious disease"

Author: Chi Heem Wong; Kien Wei Siah; Andrew W Lo
Title: Estimating Probabilities of Success of Clinical Trials for Vaccines and Other Anti-Infective Therapeutics
  • Document date: 2020_4_14
  • ID: fnrm6a79_26
    Snippet: In contrast to vaccines, which are intended to prevent disease, a number of alternatives have been developed to treat-and, in some cases, cure-patients afflicted with an infectious disease. According to our dataset, 3,851 and 2,978 industry-sponsored and non-industry-sponsored non-vaccine drug development programs, respectively, have been initiated in the area of infectious disease (see Figure 4 ). The top three diseases with the greatest number .....
    Document: In contrast to vaccines, which are intended to prevent disease, a number of alternatives have been developed to treat-and, in some cases, cure-patients afflicted with an infectious disease. According to our dataset, 3,851 and 2,978 industry-sponsored and non-industry-sponsored non-vaccine drug development programs, respectively, have been initiated in the area of infectious disease (see Figure 4 ). The top three diseases with the greatest number of industry-sponsored drug development programs are respiratory infections (21.8%), HIV (15.7%) and hepatitis C virus, or HCV (14.1%). Together, they comprise 51.6% of all industry-sponsored non-vaccine development programs. Nonindustry anti-infectious-disease drug development programs focus on treating respiratory infections (20.5%), HIV (13.9%), and bacteria skin infection (12.1%).

    Search related documents:
    Co phrase search for related documents
    • alternative number and drug development: 1
    • alternative number and great number: 1, 2
    • alternative number and infectious disease: 1, 2
    • anti infectious disease and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • bacteria skin and disease prevent: 1
    • bacteria skin and infectious disease: 1, 2
    • development program and disease prevent: 1, 2, 3
    • development program and drug development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • development program and drug development program: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • development program and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • disease prevent and drug development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • disease prevent and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • drug development and great number: 1, 2
    • drug development and industry sponsor: 1, 2
    • drug development and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • drug development program and infectious disease: 1, 2, 3
    • great number and infectious disease: 1, 2, 3, 4